{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T22:09:50Z","timestamp":1793138990211,"version":"4.5.0"},"reference-count":50,"publisher":"Association for Research in Vision and Ophthalmology (ARVO)","issue":"14","license":[{"start":{"date-parts":[[2021,12,21]],"date-time":"2021-12-21T00:00:00Z","timestamp":1640044800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Trans. Vis. Sci. Tech."],"published-print":{"date-parts":[[2021,12,21]]},"DOI":"10.1167\/tvst.10.14.24","type":"journal-article","created":{"date-parts":[[2021,12,21]],"date-time":"2021-12-21T16:43:39Z","timestamp":1640105019000},"page":"24","source":"Crossref","is-referenced-by-count":14,"title":["An Objective Perimetry Study of Central Versus Peripheral Sensitivities and Delays in Age-Related Macular Degeneration"],"prefix":"10.1167","volume":"10","author":[{"given":"Bhim B.","family":"Rai","sequence":"first","affiliation":[{"name":"John Curtin School of Medical Research, Australian National University, Australia Capital Territory, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rohan W.","family":"Essex","sequence":"additional","affiliation":[{"name":"Academic Unit, ANU Medical School, ANU, Canberra, Australia Capital Territory, Australia"},{"name":"Department of Ophthalmology, The Canberra Hospital, ACT Health, Canberra, ACT, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Faran","family":"Sabeti","sequence":"additional","affiliation":[{"name":"John Curtin School of Medical Research, Australian National University, Australia Capital Territory, Australia"},{"name":"School of Optometry, University of Canberra, Bruce, Canberra, Australia Capital Territory, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ted","family":"Maddess","sequence":"additional","affiliation":[{"name":"John Curtin School of Medical Research, Australian National University, Australia Capital Territory, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emilie M. F.","family":"Rohan","sequence":"additional","affiliation":[{"name":"John Curtin School of Medical Research, Australian National University, Australia Capital Territory, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joshua P.","family":"van Kleef","sequence":"additional","affiliation":[{"name":"John Curtin School of Medical Research, Australian National University, Australia Capital Territory, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Corinne F.","family":"Carle","sequence":"additional","affiliation":[{"name":"John Curtin School of Medical Research, Australian National University, Australia Capital Territory, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"27","reference":[{"key":"bib1","doi-asserted-by":"publisher","first-page":"e106","DOI":"10.1016\/S2214-109X(13)70145-1","article-title":"Global prevalence of age-related macular degeneration and disease burden projection for 2020 and 2040: a systematic review and meta-analysis","volume":"2","author":"Wong","year":"2014","journal-title":"Lancet Glob Health"},{"key":"bib2","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/s40662-016-0063-5","article-title":"Epidemiology of age-related macular degeneration (AMD): associations with cardiovascular disease phenotypes and lipid factors","volume":"3","author":"Pennington","year":"2016","journal-title":"Eye Vis (Lond)"},{"key":"bib3","doi-asserted-by":"publisher","first-page":"1417","DOI":"10.1001\/archopht.119.10.1417","article-title":"A Randomized, Placebo-Controlled, Clinical Trial of High-Dose Supplementation With Vitamins C and E, Beta Carotene, and Zinc for Age-Related Macular Degeneration and Vision Loss: AREDS Report No. 8","volume":"119","author":"Age-Related Eye Disease Study Research G","year":"2001","journal-title":"Arch Ophthalmol"},{"key":"bib4","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1001\/archopht.120.1.100","article-title":"AREDS investigators distort findings","volume":"120","author":"Seigel","year":"2002","journal-title":"Arch Ophthalmol"},{"key":"bib5","doi-asserted-by":"publisher","first-page":"221","DOI":"10.2174\/138945011794182755","article-title":"Age related macular degeneration and visual disability","volume":"12","author":"Christoforidis","year":"2011","journal-title":"Curr Drug Targets"},{"key":"bib6","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/j.ophtha.2006.10.040","article-title":"Fifteen-year cumulative incidence of age-related macular degeneration: the Beaver Dam Eye Study","volume":"114","author":"Klein","year":"2007","journal-title":"Ophthalmology"},{"key":"bib7","doi-asserted-by":"publisher","first-page":"1891","DOI":"10.1093\/ije\/dyx189","article-title":"HDL-cholesterol levels and risk of age-related macular degeneration: a multiethnic genetic study using Mendelian randomization","volume":"46","author":"Fan","year":"2017","journal-title":"Int J Epidemiol"},{"key":"bib8","first-page":"277","article-title":"The burden of age-related macular degeneration: a value-based medicine analysis","volume":"40","author":"Brown","year":"2005","journal-title":"Trans Am Ophthalmol Soc"},{"key":"bib9","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1038\/s41433-018-0225-x","article-title":"Asian age-related macular degeneration: from basic science research perspective","volume":"33","author":"Yanagi","year":"2019","journal-title":"Eye (Lond)"},{"key":"bib10","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1016\/j.oret.2020.04.016","article-title":"Agreement of Spectral-Domain OCT with Fluorescein Leakage in Neovascular Age-Related Macular Degeneration: Post Hoc Analysis of the HARBOR Study","volume":"4","author":"Khurana","year":"2020","journal-title":"Ophthalmol Retina"},{"key":"bib11","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.pdpdt.2015.03.007","article-title":"Vascular-targeted photodynamic therapy in the treatment of neovascular age-related macular degeneration: Clinical perspectives","volume":"12","author":"Kawczyk-Krupka","year":"2015","journal-title":"Photodiagnosis Photodyn Ther"},{"key":"bib12","doi-asserted-by":"publisher","first-page":"992","DOI":"10.1016\/j.ophtha.2012.02.002","article-title":"Verteporfin plus ranibizumab for choroidal neovascularization in age-related macular degeneration: twelve-month MONT BLANC study results","volume":"119","author":"Larsen","year":"2012","journal-title":"Ophthalmology"},{"key":"bib13","first-page":"527","article-title":"Anti-VEGF Therapy for Neovascular AMD and Polypoidal Choroidal Vasculopathy","volume":"6","author":"Cheung","year":"2017","journal-title":"Asia Pac J Ophthalmol (Phila)"},{"key":"bib14","doi-asserted-by":"publisher","first-page":"2606","DOI":"10.1056\/NEJMra0801537","article-title":"Age-Related Macular Degeneration","volume":"358","author":"Jager","year":"2008","journal-title":"N Engl J Med"},{"key":"bib15","doi-asserted-by":"publisher","first-page":"1477","DOI":"10.1097\/OPX.0b013e318235af61","article-title":"Multifocal pupillographic assessment of age-related macular degeneration","volume":"88","author":"Sabeti","year":"2011","journal-title":"Optom Vis Sci"},{"key":"bib16","doi-asserted-by":"publisher","first-page":"1707","DOI":"10.1007\/s00417-013-2273-z","article-title":"Multifocal pupillography identifies retinal dysfunction in early age-related macular degeneration","volume":"251","author":"Sabeti","year":"2013","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"bib17","first-page":"317","article-title":"Per-region visual field sensitivities and delays in AMD","volume":"62","author":"Rai","year":"2021","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"bib18","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1097\/OPX.0000000000000319","article-title":"Multifocal pupillography in early age-related macular degeneration","volume":"91","author":"Sabeti","year":"2014","journal-title":"Optom Vis Sci"},{"key":"bib19","first-page":"ABSUB","article-title":"Comparing macular and wide-field objective perimetry","volume":"9","author":"Maddess","year":"2021","journal-title":"World Glaucoma Congress"},{"key":"bib20","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1007\/s00417-019-04523-8","article-title":"Recovery dynamics of multifocal pupillographic objective perimetry from tropicamide dilation","volume":"258","author":"Rai","year":"2020","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"bib21","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1167\/iovs.11-8004","article-title":"Multifocal pupillography identifies ranibizumab-induced changes in retinal function for exudative age-related macular degeneration","volume":"53","author":"Sabeti","year":"2012","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"bib22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1167\/tvst.10.2.10","article-title":"Central versus peripheral macular structure and function: acuity in age-related macular degeneration","volume":"10","author":"Sabeti","year":"2021","journal-title":"Trans Vis Sci Tech"},{"key":"bib23","first-page":"316","article-title":"Diagnostic power of rapid ETDRS-grid matched objective perimetry in early- to late-stage AMD","volume":"62","author":"Maddess","year":"2021","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"bib24","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1001\/archopht.1993.01090060119035","article-title":"The Lens Opacities Classification System-III","volume":"111","author":"Chylack","year":"1993","journal-title":"Arch Ophthalmol"},{"key":"bib25","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1097\/OPX.0b013e31821861bd","article-title":"Measuring visual function in age-related macular degeneration with frequency-doubling (matrix) perimetry","volume":"88","author":"Anderson","year":"2011","journal-title":"Optom Vis Sci"},{"key":"bib26","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1111\/j.1442-9071.2009.02107.x","article-title":"Multifocal pupillographic visual field testing in glaucoma","volume":"30","author":"Maddess","year":"2009","journal-title":"Clin Exp Ophthalmol"},{"key":"bib27","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1111\/ceo.2014.42.issue-9","article-title":"Luminance and colour variant pupil perimetry in glaucoma","volume":"42","author":"Carle","year":"2014","journal-title":"Clin Exp Ophthalmol"},{"key":"bib28","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1002\/(ISSN)1531-8249","article-title":"Sparse multifocal stimuli for the detection of multiple sclerosis","volume":"57","author":"Ruseckaite","year":"2005","journal-title":"Ann Neurol"},{"key":"bib29","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1167\/iovs.02-0608","article-title":"The Pattern-Pulse Multifocal Visual Evoked Potential","volume":"44","author":"James","year":"2003","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"bib30","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1017\/S0952523805221053","article-title":"Effect of temporal sparseness and dichoptic presentation on multifocal visual evoked potentials","volume":"22","author":"James","year":"2005","journal-title":"Vis Neurosci"},{"key":"bib31","doi-asserted-by":"publisher","first-page":"2365","DOI":"10.1167\/iovs.10-6335","article-title":"Contraction anisocoria: segregation, summation, and saturation in the pupillary pathway","volume":"52","author":"Carle","year":"2011","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"bib32","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1167\/iovs.09-3659","article-title":"Dichoptic Multifocal Pupillography Reveals Afferent Visual Field Defects in Early Type 2 Diabetes","volume":"51","author":"Bell","year":"2010","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"bib33","doi-asserted-by":"publisher","first-page":"7343","DOI":"10.1167\/iovs.12-10881","article-title":"Pupillometric evaluation of the dynamics of the pupillary response to a brief light stimulus in healthy subjects","volume":"53","author":"Bremner","year":"2012","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"bib34","doi-asserted-by":"publisher","first-page":"7644","DOI":"10.1167\/iovs.12-11105","article-title":"Pupil dynamics and response amplitude: only size matters","volume":"53","author":"Maddess","year":"2012","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"bib35","article-title":"The normative model was based on an unpublished study (currently under review) of a cohort of 133 subjects, each tested twice, 2 weeks apart","author":"Carle","year":"2020","journal-title":"In Preparation"},{"key":"bib36","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.visres.2012.07.019","article-title":"Photopic and scotopic multifocal pupillographic responses in age-related macular degeneration","volume":"69","author":"Rosli","year":"2012","journal-title":"Vision Res"},{"key":"bib37","doi-asserted-by":"publisher","first-page":"45847","DOI":"10.1038\/srep45847","article-title":"Comparing multifocal pupillographic objective perimetry (mfPOP) and multifocal visual evoked potentials (mfVEP) in retinal diseases","volume":"7","author":"Sabeti","year":"2017","journal-title":"Sci Rep"},{"key":"bib38","first-page":"4685","article-title":"A comparative analysis of changes in visual field sensitivity in type 2 diabetes","volume":"56","author":"Sabeti","year":"2015","journal-title":"InvestOphthalmol Vis Sci"},{"key":"bib39","doi-asserted-by":"publisher","first-page":"572","DOI":"10.2174\/1389200216666151001120831","article-title":"Pharmacokinetic and Pharmacodynamic Properties of Anti-VEGF Drugs After Intravitreal Injection","volume":"16","author":"Semeraro","year":"2015","journal-title":"Curr Drug Metab"},{"key":"bib40","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1007\/s11357-019-00138-3","article-title":"Microvascular contributions to age-related macular degeneration (AMD): from mechanisms of choriocapillaris aging to novel interventions","volume":"41","author":"Lipecz","year":"2019","journal-title":"Geroscience"},{"key":"bib41","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1016\/j.molmed.2016.06.009","article-title":"A Revised Hemodynamic Theory of Age-Related Macular Degeneration","volume":"22","author":"Gelfand","year":"2016","journal-title":"Trends Mol Med"},{"key":"bib42","doi-asserted-by":"publisher","first-page":"4504","DOI":"10.1167\/iovs.15-16712","article-title":"Multifocal Pupillography Identifies Changes in Visual Sensitivity According to Severity of Diabetic Retinopathy in Type 2 Diabetes","volume":"56","author":"Sabeti","year":"2015","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"bib43","first-page":"218","article-title":"Clinical Utility of Multifocal Pupillographic Objective Perimetry in Type 1 Diabetes","volume":"54","author":"Maddess","year":"2013","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"bib44","doi-asserted-by":"publisher","first-page":"44","DOI":"10.4103\/0974-620X.176100","article-title":"The effect of intravitreal bevacizumab and ranibizumab on macular edema of the contralateral eye: A comparative study of two anti-VEGFs","volume":"9","author":"Bakbak","year":"2016","journal-title":"Oman J Ophthalmol"},{"key":"bib45","doi-asserted-by":"publisher","first-page":"357","DOI":"10.2147\/CIA","article-title":"Effects of intravitreal ranibizumab on the untreated eye and systemic gene expression profile in age-related macular degeneration","volume":"11","author":"Michalska-Malecka","year":"2016","journal-title":"Clin Interv Aging"},{"key":"bib46","first-page":"2133","article-title":"Systemic Side Effects and Risks Associated With Bilateral Anti-VEGF Injections","volume":"49","author":"El-Sanhouri","year":"2008","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"bib47","doi-asserted-by":"publisher","first-page":"1299","DOI":"10.1517\/14712598.2012.707176","article-title":"Systemic thromboembolic adverse events in patients treated with intravitreal anti-VEGF drugs for neovascular age-related macular degeneration","volume":"12","author":"Costagliola","year":"2012","journal-title":"Expert Opin Biol Ther"},{"key":"bib48","doi-asserted-by":"publisher","first-page":"1847","DOI":"10.1097\/IAE.0000000000001493","article-title":"Systemic Pharmacokinetics and Pharmacodynamics of Intravitreal Aflibercept, Bevacizumab, and Ranibizumab","volume":"37","author":"Avery","year":"2017","journal-title":"Retina"},{"key":"bib49","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1111\/aos.2015.93.issue-2","article-title":"Systemic levels of vascular endothelial growth factor before and after intravitreal injection of aflibercept or ranibizumab in patients with age-related macular degeneration: a randomised, prospective trial","volume":"93","author":"Zehetner","year":"2015","journal-title":"Acta Ophthalmologica"},{"key":"bib50","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1111\/ceo.2017.45.issue-5","article-title":"To BCVA, or not to BCVA, that is the question","volume":"45","author":"Maddess","year":"2017","journal-title":"Clin Exp Ophthalmol"}],"container-title":["Translational Vision Science & Technology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/tvst.arvojournals.org\/article.aspx?articleid=2778173","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,21]],"date-time":"2021-12-21T16:43:51Z","timestamp":1640105031000},"score":1,"resource":{"primary":{"URL":"https:\/\/tvst.arvojournals.org\/article.aspx?articleid=2778173"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12,21]]},"references-count":50,"journal-issue":{"issue":"14","published-print":{"date-parts":[[2021,12,1]]}},"URL":"https:\/\/doi.org\/10.1167\/tvst.10.14.24","relation":{},"ISSN":["2164-2591"],"issn-type":[{"value":"2164-2591","type":"print"}],"subject":[],"published":{"date-parts":[[2021,12,21]]}}}